Key result
Female sex linked to ~31% lower risk of major events versus males after early-onset MI.
Why the study?
It remains unclear whether sex-related differences in cardiovascular risk extend to pre-menopausal females experiencing early-onset myocardial infarction.
Does female sex improve long-term outcomes in patients with early-onset myocardial infarction?
Cohort (n=2,000)
Yes
Does female sex improve long-term outcomes in patients with early-onset myocardial infarction?
Effect estimate: aHR 0.69 (95% CI 0.52-0.91)
Absolute Event Rate: 26.1% vs 37.2%
p-value: p=0.01
Women experiencing early-onset myocardial infarction have a lower baseline atherosclerotic burden and better long-term outcomes compared to men, despite receiving fewer secondary prevention medications.
Suggests better prognosis for women after early MI; extends sex-difference data but remains hypothesis-generating.
Importance There is growing awareness of sex-related differences in cardiovascular risk profiles, but less is known about whether these extend to pre-menopausal females experiencing an early-onset myocardial infarction (MI), who may benefit from the protective effects of estrogen exposure. Methods A nationwide study involving 125 Italian Coronary Care Units recruited 2,000 patients between 1998 and 2002 hospitalized for a type I myocardial infarction before the age of 45 years (male, n = 1,778 (88.9%). Patients were followed up for a median of 19.9 years (IQR 18.1–22.6). The primary composite endpoint was the occurrence of cardiovascular death, non-fatal myocardial re-infarction or non-fatal stroke, and the secondary endpoint of hospitalization for revascularisation by means of a percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG). Results ST-elevation MI was the most frequent presentation among both men and women (85.1 vs. 87.4%, p = ns), but the men had a greater baseline coronary atherosclerotic burden (median Duke Coronary Artery Disease Index: 48 vs. 23; median Syntax score 9 vs. 7; both p < 0.001). The primary composite endpoint occurred less frequently among women (25.7% vs. 37.0%; adjusted hazard ratio: 0.69, 95% CI 0.52–0.91; p = 0.01) despite being less likely to receive treatment with most secondary prevention medications during follow up. Conclusions There are significant sex-related differences in baseline risk factors and outcomes among patients with early-onset MI: women present with a lower atherosclerotic disease burden and, although they are less frequently prescribed secondary prevention measures, experience better long-term outcomes. Trial Registration 4272/98 Ospedale Niguarda, Ca' Granda 03/09/1998.
No takes yet. Share an insight, caveat, or question.
Ardissino et al. (2022) conducted a cohort in Early-onset myocardial infarction (n=2,000). Female sex vs. Male sex was evaluated on Composite of cardiovascular death, non-fatal myocardial re-infarction, or non-fatal ischemic stroke (aHR 0.69, 95% CI 0.52-0.91, p=0.01). Female sex was associated with a 31% lower risk of cardiovascular death, non-fatal re-infarction, or stroke compared to male sex (aHR 0.69) following early-onset myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: